J&J CORDIS UNIT SEES FDA WARNING LETTER RESOLVED SOON

Johnson & Johnson's Cordis Corp. unit, which makes coronary stents, expects to resolve an outstanding warning letter from the Food and Drug Administration later this year, group chairman Rick Anderson said Wednesday during the health-care giant's medical devices and diagnostics business review with analysts.
MarketWatch